SCHEMBL3236826

SCHEMBL3236826

Cc1csc(N(C(=O)CCCCCC(N)=O)c2cc(F)ccc2N)n1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.38
▸ GCK P35557 5/20 0.36
▸ LMNA P02545 2/20 0.35
▸ MAPK14 Q16539 1/20 0.34
▸ PTGDR2 Q9Y5Y4 1/20 0.34
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ GSTO1 P78417 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ SLC12A5 Q9H2X9 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ PYGL P06737 1/20 0.32
▸ TGFBR1 P36897 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3233610 0.92 KDM4E (0.38) KDM4EGCKLMNAMAPK14PTGDR2
SCHEMBL3233744 0.82 KMT2A (0.47) KDM4ELMNAMAPK14NPC1RAB9A
SCHEMBL3232041 0.81 HDAC1 (0.34) KDM4ENPC1RAB9AHDAC3HDAC1
SCHEMBL3237150 0.81 HDAC1 (0.41) KDM4ELMNANPC1RAB9AHDAC3
SCHEMBL3238619 0.78 KDM4E (0.34) KDM4ELMNAMAPK14HDAC3HDAC1
SCHEMBL3232050 0.78 HDAC3 (0.40) NPC1RAB9AHDAC3HDAC1ALDH1A1
SCHEMBL3227664 0.78 HDAC1 (0.32) MAPK14PTGDR2HDAC3HDAC1
SCHEMBL3240737 0.78 MAPK14 (0.48) LMNAMAPK14NPC1RAB9AHDAC1
SCHEMBL3235671 0.76 GRM1 (0.44) MAPK14NPC1RAB9AHDAC1TDP1
SCHEMBL3262238 0.73 HDAC3 (0.35) HDAC3HDAC1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010028193-A1 COMPOUNDS INCLUDING PIMELIC ACID DERIVATIVES AS HDAC INHIBITORS REPLIGEN CORPORATION (US) 2010-03-11 — — WO disclosed
Send feedback